According to the pharmaceutical company, the trial of the drug is stopped on seriously ill covid-19 patients who are hospitalized. This is done on the advice of independent experts who continuously monitor the effects of the drug.
The drug will continue to be tested on less ill patients, Regeneron Pharmaceuticals states.
This is the second time in a short time that testing of a new antibody drug has been stopped. Earlier this month, it happened after warnings about possible side effects associated with a drug developed by Eli Lilly and Company in the United States.
(© NTB)
These were the details of the news Trial of coronary medicine is stopped for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at time24.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
